XFRA
BZ7A
Market cap4.39bUSD
Jun 18, Last price
4.88EUR
1D
1.24%
1Q
14.55%
Name
Bumrungrad Hospital PCL
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Bumrungrad Hospital Public Company Limited (BUGDF) is a leading healthcare provider that operates a network of medical facilities in Thailand and globally. Its core offering is a comprehensive medical center equipped with advanced diagnostic, therapeutic, and intensive care capabilities. The company also boasts an extensive array of approximately 56 specialized outpatient clinics and centers, covering a broad spectrum of medical disciplines. These include, but are not limited to, allergy, cardiology, behavioral health, oncology, dental, diabetes, emergency services, eye care, fertility, digestive disease, women's health, men's health, orthopedics, physical therapy, plastic surgery, and sleep medicine. Beyond direct patient care, Bumrungrad engages in various related activities. These encompass managing real estate holdings, conducting clinical research, distributing pharmaceutical and medical goods through dedicated stores, operating a training and development center for healthcare professionals, and providing patient referral services. With its substantial infrastructure, the company maintains 580 hospital beds across its facilities. Founded in 1980, Bumrungrad Hospital Public Company Limited is headquartered in Bangkok, Thailand.
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||